Clinical Outcomes of Renin-Angiotensin-Aldosterone Blockade in Patients With Advanced Chronic Kidney Disease: A Systematic Review and Meta-analysis
Open Access
- 6 March 2024
- journal article
- review article
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 40 (9) , 1718-1728
Abstract
No abstract availableKeywords
Funding Information
- Fonds de Recherche du Québec Santé
This publication has 40 references indexed in Scilit:
- Effectiveness and Tolerance of Renin-Angiotensin System Inhibitors With Aging in Chronic Kidney DiseaseJournal of the American Medical Directors Association, 2022
- ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3–5: A Network Meta-Analysis of Randomised Clinical TrialsDrugs, 2020
- Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration RateJAMA Internal Medicine, 2020
- Revisiting RAAS blockade in CKD with newer potassium-binding drugsKidney International, 2018
- Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal DysfunctionJACC, 2016
- Renoprotective Effect of Renin-Angiotensin-Aldosterone System Blockade in Patients With Predialysis Advanced Chronic Kidney Disease, Hypertension, and AnemiaJAMA Internal Medicine, 2014
- Renin-Angiotensin Inhibition in Systolic Heart Failure and Chronic Kidney DiseaseThe American Journal of Medicine, 2012
- Renoprotective effects of angiotensin II receptor blocker, candesartan cilexetil, in patients with stage 4–5 chronic kidney diseaseClinical and Experimental Nephrology, 2008
- Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: A meta-analysisAmerican Heart Journal, 2008
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986